See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Avonex, Avonex Prefilled Syringe
Generic Name: Interferon beta-1a IM Injection
What is Interferon beta-1a IM Injection? Interferon beta-1a is a drug in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells while Interferon beta-1b is produced in modified E. coli. Interferons have been shown to have about a 30–35% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients.
See more information, including instructions, precautions, side effects, and interactions.
1657 patients in the community are taking or have taken Interferon beta-1a IM Injection.
Top 10 (Show all)
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 1286 | 77% |
| Other | 51 | 3% |
| General health | 18 | 1% |
| Multiple Sclerosis (MS) | 13 | <1% |
| Don't know | 10 | <1% |
| Fatigue | 8 | <1% |
| Stiffness/Spasticity | 8 | <1% |
| Vision | 3 | <1% |
| disease-related symptoms | 2 | <1% |
| 1st MS treatment 2001-2002 | 2 | <1% |
Other treatments patients are taking for Slow my MS progress include Glatiramer acetate, Interferon beta-1a SubQ injection, and Interferon beta-1b SubQ Injection.
Based on the patients currently taking Interferon beta-1a IM Injection.
Top 10 (Show all)
All (Show top 10)
| 300mcg as needed | daily | weekly | 0.05 mcg weekly | 0.25 mg weekly | 0.25 mL weekly | 0.325 mcg weekly | 0.5 mcg weekly | 0.5 mg weekly | 0.5 ml weekly | 0.5 weekly | 1 mcg weekly | 1 mg weekly | 1 mL weekly | 1 other weekly | 1 weekly | 1.5 mcg weekly | 1.5 mg weekly | 4 weekly | 5 mcg weekly | 30 mcg monthly | 30 mcg/0.5 mL weekly | 10 mg weekly | 13.2 mg weekly | 2 mcg daily | 15 mcg weekly | 15 mg weekly | 30 mcg every other week | 33 mcg every other week | 20 mcg weekly | 22 mcg/0.5 mL weekly | 24 mcg weekly | 30 mcg/0.5 mL weekly | 30 mcg weekly | 30 mg weekly | 30 mmol/L weekly | 30 weekly | 33 mcg weekly | 35 mcg weekly | 37 mcg weekly | 44 mcg/0.5 mL weekly | 44 mg weekly | 50 mcg weekly | 50 mg weekly | 60 mcg weekly | 3 x 22 mcg/0.5 mL weekly | 80 mg weekly | 100 mcg weekly | 125 mcg weekly | 3 x 44 mcg/0.5 mL weekly | 200 mcg weekly | 30 mcg/0.5 mL daily | 30 mcg daily | 30.1 mcg daily | 44 mcg/0.5 mL daily | 360 mg weekly | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
173
|
1
|
2
|
1
|
1
|
6
|
2
|
1
|
2
|
18
|
10
|
3
|
2
|
10
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
1
|
215
|
386
|
23
|
1
|
10
|
3
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
7
|
27
|
20
|
1
|
2
|
1
|
||
How long current patients have been taking Interferon beta-1a IM Injection or how long patients were taking Interferon beta-1a IM Injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 304 | 44% | |
| Did not seem to work | 252 | 37% | |
| Doctor's advice | 216 | 31% | |
| Other | 131 | 19% | |
| Expense | 28 | 4% | |
| Personal research | 21 | 3% | |
| Not indicated | 10 | 1% | |
| Course of treatment ended | 7 | 1% |
Results from 306 patient evaluations. See the overall results and all individual evaluations.
| Major | 17% | 48 |
|---|---|---|
| Moderate | 19% | 53 |
| Slight | 8% | 22 |
| None | 8% | 22 |
| Can't tell | 48% | 136 |
Slow my MS progress
| Severe | 20% | 61 |
|---|---|---|
| Moderate | 40% | 121 |
| Mild | 34% | 103 |
| None | 7% | 21 |
Top reported side-effects include: Flu-like symptoms, Chills/fever, Body Aches
Summary results are based on 306 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Interferon beta-1a IM Injection
Report created on November 07, 2009.